ES2054988T3 - Quinuclidinas, su empleo como medicamentos y procedimiento para su produccion. - Google Patents

Quinuclidinas, su empleo como medicamentos y procedimiento para su produccion.

Info

Publication number
ES2054988T3
ES2054988T3 ES89121387T ES89121387T ES2054988T3 ES 2054988 T3 ES2054988 T3 ES 2054988T3 ES 89121387 T ES89121387 T ES 89121387T ES 89121387 T ES89121387 T ES 89121387T ES 2054988 T3 ES2054988 T3 ES 2054988T3
Authority
ES
Spain
Prior art keywords
procedure
production
quinuclidines
medicines
quinolimimetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89121387T
Other languages
English (en)
Inventor
Gerhard Dr Walther
Karl-Heinz Dr Weber
Werner Dr Stransky
Franz Dr Kuhn
Enzio Prof Dr Muller
Helmut Dr Ensinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim GmbH
Original Assignee
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim GmbH
Application granted granted Critical
Publication of ES2054988T3 publication Critical patent/ES2054988T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL INVENTO SE REFIERE A NUEVA QUINUCLIDINA; TRATA DE UN PROCEDIMIENTO PARA SU PRODUCCION Y DESCRIBE LA APLICACION COMO MEDICAMENTEO CON PROPIEDADES QUINOLIMIMETICAS.
ES89121387T 1988-11-22 1989-11-18 Quinuclidinas, su empleo como medicamentos y procedimiento para su produccion. Expired - Lifetime ES2054988T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3839385A DE3839385A1 (de) 1988-11-22 1988-11-22 Neue quinuclidine, ihre herstellung als arzneimittel und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES2054988T3 true ES2054988T3 (es) 1994-08-16

Family

ID=6367625

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89121387T Expired - Lifetime ES2054988T3 (es) 1988-11-22 1989-11-18 Quinuclidinas, su empleo como medicamentos y procedimiento para su produccion.

Country Status (18)

Country Link
US (2) US5451587A (es)
EP (1) EP0370415B1 (es)
JP (1) JPH0686449B2 (es)
KR (1) KR0165667B1 (es)
AU (1) AU628884B2 (es)
BG (1) BG61859B2 (es)
CA (1) CA2003422C (es)
DE (3) DE3839385A1 (es)
DK (1) DK170167B1 (es)
ES (1) ES2054988T3 (es)
FI (1) FI91637C (es)
HU (1) HU202527B (es)
IE (1) IE62328B1 (es)
IL (1) IL92377A (es)
NO (1) NO172801C (es)
NZ (1) NZ231445A (es)
PT (1) PT92368B (es)
ZA (1) ZA898858B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1307790C (en) * 1987-08-04 1992-09-22 Ian Anthony Cliffe Ethers
YU84791A (sh) * 1990-05-19 1994-06-10 Boehringer Ingelheim Kg. Biciklicni 1-aza-cikloalkalni
EP0492904A1 (en) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituted benzene derivatives for use in the treatment of glaucoma
EP0492902A1 (en) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituted pyridine derivatives for use in the treatment of glaucoma
EP0492903A1 (en) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma
ZA92278B (en) * 1991-02-01 1992-10-28 Akzo Nv 3-quinuclidine derivatives
GB9122988D0 (en) * 1991-10-30 1991-12-18 Ici Plc Heterocyclic compounds
GB9127279D0 (en) * 1991-12-23 1992-02-19 Ici Plc Heterocyclic derivatives
JPH06508377A (ja) * 1992-04-10 1994-09-22 ゼネカ　リミテッド ヘテロ環式化合物
GB9211796D0 (en) * 1992-06-04 1992-07-15 Ici Plc Heterocyclic derivatives
GB9216721D0 (en) * 1992-08-06 1992-09-23 Ici Plc Therapeutic heterocyclic derivatives
GB9218334D0 (en) * 1992-08-28 1992-10-14 Ici Plc Heterocyclic compounds
DE4236331A1 (de) * 1992-10-28 1994-05-05 Boehringer Ingelheim Kg Synergistische Kombination
GB9226573D0 (en) * 1992-12-21 1993-02-17 Ici Plc Heterocyclic compounds
US5998404A (en) * 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5512574A (en) * 1994-12-21 1996-04-30 American Home Products Corporation Quinuclidine and azabicyclo 2.2.1! heptane pyrazinyl ethers as muscarinic agonists
EP0785198B1 (de) 1996-01-19 2000-07-05 Lonza Ag Verfahren zur Herstellung von optisch aktivem 3-Chinuclidinol
SE9600683D0 (sv) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
CZ54498A3 (cs) * 1997-03-07 1998-11-11 Lonza Ag Katalyzátorová směs na bázi amorfního částečně dehydratovaného hydroxidu zirkoničitého a způsob její výroby a použití
WO1998046225A1 (en) * 1997-04-11 1998-10-22 Eli Lilly And Company Method for treating schizophrenia
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
DE10106971A1 (de) * 2001-02-15 2002-08-29 Boehringer Ingelheim Pharma Arzneimittelformulierung die einen muskarinischen Agonisten enthält
KR100448002B1 (ko) * 2002-02-01 2004-09-13 한국과학기술연구원 신규한 퀴누클리딘 화합물 및 그 제조방법
KR20030083289A (ko) * 2002-04-20 2003-10-30 한승호 다공질 화분
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
PE20060437A1 (es) 2004-06-18 2006-06-08 Novartis Ag COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1928437A2 (en) * 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
GB0521508D0 (en) 2005-10-21 2005-11-30 Novartis Ag Organic compounds
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20210251970A1 (en) 2018-10-10 2021-08-19 Presbyopia Therapies Inc Compositions and methods for storage stable ophthalmic drugs
WO2020117637A1 (en) * 2018-12-05 2020-06-11 Presbyopia Therapies Llc Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof
US12180206B2 (en) 2021-11-17 2024-12-31 Lenz Therapeutics Operations, Inc. Aceclidine derivatives, compositions thereof and methods of use thereof
US12414942B1 (en) 2024-03-15 2025-09-16 Lenz Therapeutics Operations, Inc. Compositions, methods, and systems for treating presbyopia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2014831A1 (en) * 1968-08-01 1970-04-24 Sogeras Quinuclidinyl and quinuclidinylalkyl ethers with cholino - lytic, antihistaminic and neurosedative activity
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR900007837A (ko) 1990-06-02
FI91637B (fi) 1994-04-15
IL92377A0 (en) 1990-07-26
CA2003422A1 (en) 1990-05-22
JPH02243688A (ja) 1990-09-27
HU202527B (en) 1991-03-28
NO172801C (no) 1993-09-08
FI91637C (fi) 1994-07-25
IE893712L (en) 1990-05-22
NZ231445A (en) 1991-08-27
CA2003422C (en) 1999-12-21
IE62328B1 (en) 1995-01-25
HUT53102A (en) 1990-09-28
HU896032D0 (en) 1990-02-28
EP0370415A1 (de) 1990-05-30
NO894630D0 (no) 1989-11-21
DK170167B1 (da) 1995-06-06
PT92368B (pt) 1995-07-18
DE3839385A1 (de) 1990-05-23
EP0370415B1 (de) 1993-06-02
JPH0686449B2 (ja) 1994-11-02
ZA898858B (en) 1991-07-31
IL92377A (en) 1995-01-24
NO894630L (no) 1990-05-23
DE8817121U1 (de) 1993-02-04
AU4540389A (en) 1990-05-31
DE58904567D1 (de) 1993-07-08
KR0165667B1 (ko) 1999-01-15
BG61859B2 (bg) 1998-07-31
DK584089A (da) 1990-05-23
US5451587A (en) 1995-09-19
US5508405A (en) 1996-04-16
DK584089D0 (da) 1989-11-21
PT92368A (pt) 1990-05-31
FI895531A0 (fi) 1989-11-21
NO172801B (no) 1993-06-01
AU628884B2 (en) 1992-09-24

Similar Documents

Publication Publication Date Title
ES2054988T3 (es) Quinuclidinas, su empleo como medicamentos y procedimiento para su produccion.
MX9304819A (es) Nuevos derivados de xantina y procedimiento para su preparacion.
ES2086313T3 (es) Nuevos derivados de xantina con efecto antagonista de adenosina.
SV1995000042A (es) Heteroaril-oxazolidinonas de 5 eslabones ref. le a 30523-sv
SV1997000003A (es) Tienil- y furanil-oxazolidinonas piridocondensadas ref. lea 31502-sv
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
SV1996000026A (es) Benzociclopentano oxazolidinonas que contienen heteroatomos
ES2003863B3 (es) Nueva preparacion farmaceutica con liberacion controlada de metoprolol, metodo para su fabricacion y uso de la nueva preparacion.
ES2080768T3 (es) Cuerpos moldeados resorbibles y procedimiento para su produccion.
SV1997000002A (es) 2-oxo y 2-tio-1,2-dihidroquinolinil-oxazolidinonas ref. lea 31477-sv
UY26962A1 (es) Monohidrato cristalino, procedimiento para su preparación y su utilización para la preparación de un medicamento
SV1999000048A (es) Uso de dihidropiriminas como medicamento y nuevas sustancias ref. lea 32 791-sv
DE69017167D1 (de) Organisches polymer, dessen herstellung und härtbare zusammensetzung, die es enthält.
MX9301129A (es) Nuevas ciclosporinas y composiciones farmaceuticas que las contienen.
ES522916A0 (es) Procedimiento para la produccion de n-acilo-polipeptidos (como desglose y con prioridad de la patente espanola n 510.167, presentada el 5 de marzo de 1.982).
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
ES556313A0 (es) Procedimiento para la produccion de gamma-butirolactona.
AR025052A1 (es) Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos.
ES2042742T3 (es) Procedimiento para preparar furanonas antiinflamatorias.
ES2134787T3 (es) Derivados de poliaspartamida como agentes de adsorcion para acidos biliares, derivados de poliaspartamida cargados con acidos biliares, y procedimiento para su preparacion, asi como su utilizacion como medicamentos.
IT1219542B (it) Derivati pepticidi,loro preparazione e loro impiego come medicamenti
ES2059457T3 (es) Utilizacion de bezafibrato para el tratamiento de la diabetes.
ES2060127T3 (es) Halogenoalquilfenil-alcoholes-cetonas y sus hidratos.
ES2033869T3 (es) Figura de muneco saltador de juguete.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 370415

Country of ref document: ES